These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25732625)

  • 1. Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial.
    Kim DD; Krishnarajah J; Lillioja S; de Looze F; Marjason J; Proietto J; Shakib S; Stuckey BGA; Vath JE; Hughes TE
    Diabetes Obes Metab; 2015 Jun; 17(6):566-572. PubMed ID: 25732625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial.
    Proietto J; Malloy J; Zhuang D; Arya M; Cohen ND; de Looze FJ; Gilfillan C; Griffin P; Hall S; Nathow T; Oldfield GS; O'Neal DN; Roberts A; Stuckey BGA; Yue D; Taylor K; Kim D
    Diabetologia; 2018 Sep; 61(9):1918-1922. PubMed ID: 29992370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, placebo-controlled trial of beloranib for the treatment of hypothalamic injury-associated obesity.
    Shoemaker A; Proietto J; Abuzzahab MJ; Markovic T; Malloy J; Kim DD
    Diabetes Obes Metab; 2017 Aug; 19(8):1165-1170. PubMed ID: 28261955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial.
    McCandless SE; Yanovski JA; Miller J; Fu C; Bird LM; Salehi P; Chan CL; Stafford D; Abuzzahab MJ; Viskochil D; Barlow SE; Angulo M; Myers SE; Whitman BY; Styne D; Roof E; Dykens EM; Scheimann AO; Malloy J; Zhuang D; Taylor K; Hughes TE; Kim DD; Butler MG
    Diabetes Obes Metab; 2017 Dec; 19(12):1751-1761. PubMed ID: 28556449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women.
    Hughes TE; Kim DD; Marjason J; Proietto J; Whitehead JP; Vath JE
    Obesity (Silver Spring); 2013 Sep; 21(9):1782-8. PubMed ID: 23512440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust Reductions of Excess Weight and Hyperphagia by Beloranib in Rat Models of Genetic and Hypothalamic Obesity.
    Elfers CT; Roth CL
    Endocrinology; 2017 Jan; 158(1):41-55. PubMed ID: 27849360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspergillus, angiogenesis, and obesity: the story behind beloranib.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2015 Mar; 53(3):13-6. PubMed ID: 25751824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Efficacy and Safety of the Novel Antidiabetic, Antiobesity MetAP2 Inhibitor ZGN-1061.
    Burkey BF; Hoglen NC; Inskeep P; Wyman M; Hughes TE; Vath JE
    J Pharmacol Exp Ther; 2018 May; 365(2):301-313. PubMed ID: 29491038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.
    Pi-Sunyer FX; Aronne LJ; Heshmati HM; Devin J; Rosenstock J;
    JAMA; 2006 Feb; 295(7):761-75. PubMed ID: 16478899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.
    Kopelman P; Bryson A; Hickling R; Rissanen A; Rossner S; Toubro S; Valensi P
    Int J Obes (Lond); 2007 Mar; 31(3):494-9. PubMed ID: 16953261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging medications for overweight or obesity in people with comorbidities.
    Fujioka K
    Diabetes Obes Metab; 2015 Nov; 17(11):1021-32. PubMed ID: 26040215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study.
    Ettinger MP; Littlejohn TW; Schwartz SL; Weiss SR; McIlwain HH; Heymsfield SB; Bray GA; Roberts WG; Heyman ER; Stambler N; Heshka S; Vicary C; Guler HP
    JAMA; 2003 Apr; 289(14):1826-32. PubMed ID: 12684362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
    Chanoine JP; Hampl S; Jensen C; Boldrin M; Hauptman J
    JAMA; 2005 Jun; 293(23):2873-83. PubMed ID: 15956632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Horizons in the Pharmacotherapy of Obesity.
    Arch JR
    Curr Obes Rep; 2015 Dec; 4(4):451-9. PubMed ID: 26346394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.
    Astrup A; Rössner S; Van Gaal L; Rissanen A; Niskanen L; Al Hakim M; Madsen J; Rasmussen MF; Lean ME;
    Lancet; 2009 Nov; 374(9701):1606-16. PubMed ID: 19853906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial.
    Fidler MC; Sanchez M; Raether B; Weissman NJ; Smith SR; Shanahan WR; Anderson CM;
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3067-77. PubMed ID: 21795446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single and multiple dose evaluation of a novel MetAP2 inhibitor: Results of a randomized, double-blind, placebo-controlled clinical trial.
    Malloy J; Zhuang D; Kim T; Inskeep P; Kim D; Taylor K
    Diabetes Obes Metab; 2018 Aug; 20(8):1878-1884. PubMed ID: 29577550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-month efficacy and safety of amfepramone in obese Mexican patients: a double-blinded, randomized, controlled trial.
    Soto-Molina H; Pizarro-Castellanos M; Rosado-Pérez J; Rizzoli-Córdoba A; Lara-Padilla E; del Valle-Laisequilla CF; Reyes-García JG
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):541-9. PubMed ID: 26073353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.